Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
PUT
American Tower
AMT
$78.8B
| $278K | ﹤0.01% |
2,100
-32,000
| -94% | -$4.1M |
|
4027
PUT
FMC
FMC
$1.31B
| $278K | ﹤0.01% |
4,381
-3,690
| -46% | -$238K |
|
|
FPRX
4028
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $278K | ﹤0.01% |
9,249
-6,295
| -40% | -$196K |
|
|
NAVG
4029
DELISTED
Navigators Group Inc
NAVG
| $278K | ﹤0.01% |
5,051
+141
| +3% | +$7.5K |
|
4030
AMN Healthcare
AMN
$1.42B
| $277K | ﹤0.01% |
7,103
+2,051
| +41% | +$78.7K |
|
4031
CALL
Copart
CPRT
$27.4B
| $277K | ﹤0.01% |
34,800
+30,000
| +625% | +$230K |
|
4032
PUT
Hilton Grand Vacations
HGV
$3.3B
| $277K | ﹤0.01% |
7,690
-1,060
| -12% | -$36.6K |
|
|
ZNGA
4033
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $277K | ﹤0.01% |
76,100
-49,200
| -39% | -$161K |
|
|
QEP
4034
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $277K | ﹤0.01% |
27,400
-35,800
| -57% | -$388K |
|
|
TCF
4035
DELISTED
TCF Financial Corporation Common Stock
TCF
| $277K | ﹤0.01% |
5,710
-2,339
| -29% | -$112K |
|
|
KMG
4036
DELISTED
KMG Chemicals Inc
KMG
| $277K | ﹤0.01% |
5,690
-3,475
| -38% | -$178K |
|
4037
Griffon
GFF
$4.74B
| $276K | ﹤0.01% |
12,571
+11,338
| +920% | +$261K |
|
4038
PUT
MGIC Investment
MTG
$6.21B
| $276K | ﹤0.01% |
+24,600
| New | +$265K |
|
4039
Universal Insurance Holdings
UVE
$1.21B
| $276K | ﹤0.01% |
10,925
-326
| -3% | -$8.02K |
|
4040
CALL
AeroVironment
AVAV
$9.58B
| $275K | ﹤0.01% |
7,200
+6,100
| +555% | +$185K |
|
4041
J&J Snack Foods
JJSF
$1.68B
| $275K | ﹤0.01% |
2,085
+10
| +0.5% | +$1.33K |
|
|
LUMO
4042
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $275K | ﹤0.01% |
4,156
-6,037
| -59% | -$747K |
|
|
POLY
4043
DELISTED
Plantronics, Inc.
POLY
| $275K | ﹤0.01% |
5,260
+4,295
| +445% | +$231K |
|
|
ARD
4044
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $275K | ﹤0.01% |
+12,221
| New | +$270K |
|
4045
St. Joe Company
JOE
$3.78B
| $274K | ﹤0.01% |
14,530
+3,566
| +33% | +$63.2K |
|
4046
Vanguard Total International Stock ETF
VXUS
$162B
| $274K | ﹤0.01% |
+5,274
| New | +$271K |
|
|
MTGE
4047
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $274K | ﹤0.01% |
14,537
-308,134
| -95% | -$5.57M |
|
4048
PUT
Amphenol
APH
$207B
| $273K | ﹤0.01% |
+14,800
| New | +$270K |
|
4049
PUT
ITT
ITT
$19B
| $273K | ﹤0.01% |
6,800
+1,400
| +26% | +$55.8K |
|
|
INOV
4050
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $273K | ﹤0.01% |
20,755
+15,532
| +297% | +$202K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.